Interventions Related to Takayasu Arteritis, their Clinical and Angiographic Associations, and Prognostic Relevance -

Sandeep Balakrishnan1, Upendra Rathore1, Mishra Prabhaker2

  • 1Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences (SGPGIMS), Lucknow, India.

Insights

About one-sixth of patients with Takayasu arteritis (TAK) underwent interventions, primarily endovascular procedures. Multiple interventions were needed for one-fourth of these patients, yet survival rates remained similar between those who received interventions and those who did not.

Area of Science:

  • Vascular Surgery
  • Cardiology
  • Rheumatology

Background:

  • Takayasu arteritis (TAK) is a large vessel vasculitis affecting the aorta and its branches.
  • Interventions are sometimes necessary for managing complications of TAK, but their associations and impact on prognosis are not fully understood.

Purpose of the Study:

  • To analyze interventions in a large cohort of patients with Takayasu arteritis.
  • To investigate pre-treatment clinical and angiographic factors associated with interventions.
  • To assess the prognostic relevance of interventions in TAK.

Main Methods:

  • Analysis of a large ambispective, monocentric cohort of 238 patients with TAK.
  • Retrieved data on endovascular or open surgical interventions.
  • Compared demographic, clinical, and angiographic features using multivariable-adjusted odds ratios (OR) and assessed mortality using hazard ratios (HR).

Main Results:

  • 17.23% (41/238) of patients underwent 69 interventions, predominantly endovascular (64 procedures).
  • Renal arteries, subclavian arteries, and descending thoracic aorta were most commonly intervened upon.
  • Patients requiring interventions more frequently presented with abdominal angina and less often with constitutional symptoms; survival was similar between intervened and non-intervened groups (HR 0.91, 95%CI 0.23-3.55).

Conclusions:

  • Endovascular interventions are common in Takayasu arteritis management, with a significant proportion requiring multiple procedures.
  • Clinical presentation, particularly abdominal angina, is associated with the need for interventions.
  • Interventions in TAK do not appear to significantly impact long-term survival.
Abstract

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
39
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
23
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
58
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
35
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
35